Filing Details
- Accession Number:
- 0000874716-25-000125
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2025-08-08 20:37:18
- Reporting Period:
- 2025-08-06
- Filing Date:
- 2025-08-08
- Accepted Time:
- 2025-08-08 20:37:18
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 874716 | Idexx Laboratories Inc | IDXX | In Vitro & In Vivo Diagnostic Substances (2835) | 010393723 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1740689 | Michael Lane | One Idexx Drive Westbrook ME 04092 | Executive Vice President | No | Yes | No | No |
Transaction Summary
| Sold: | 8,411 shares | Avg. Price: $627.74 | Total Value: $5,279,893.41 |
| Number of Shares After Transactions: | 7,132 shares | ||
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2025-08-06 | 1,286 | $206.94 | 8,418 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2025-08-06 | 7,125 | $288.78 | 15,543 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2025-08-06 | 5,631 | $627.56 | 9,912 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2025-08-06 | 2,480 | $627.99 | 7,432 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2025-08-06 | 300 | $628.89 | 7,132 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Non-Qualified Stock Option (right-to-buy) | Disposition | 2025-08-06 | 1,286 | $0.00 | 1,286 | $206.94 |
| Common Stock | Non-Qualified Stock Option (right-to-buy) | Disposition | 2025-08-06 | 7,125 | $0.00 | 7,125 | $288.78 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2029-02-13 | No | 4 | M | Direct | |
| 0 | 2030-02-13 | No | 4 | M | Direct |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock | 592 | Indirect | by spouse |
Footnotes
- Includes a total of 28.7090 shares purchased under the Issuer Employee Stock Purchase Plan on March 31, 2025 and June 30, 2025.
- Represents the weighted average price of the shares sold ranging from a low of $626.70 to a high of $627.69 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price.
- Represents the weighted average price of the shares sold ranging from a low of $627.70 to a high of $628.62 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price.
- Represents the weighted average price of the shares sold ranging from a low of $628.82 to a high of $628.94 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price.
- Held by the reporting person's spouse in an IRA account. The reporting person disclaims beneficial ownership of the shares of common stock held by his spouse except to the extent of his pecuniary interest therein.
- Grant of option to buy 8,366 shares of Issuer common stock that became exercisable in five annual installments beginning February 14, 2020.
- Grant of option to buy 7,125 shares of Issuer common stock that became exercisable in four annual installments beginning February 14, 2021.
Billionaire Hedge Funds
